<?xml version="1.0" encoding="UTF-8"?>
<ref id="pntd.0007860.ref124">
 <label>124</label>
 <mixed-citation publication-type="journal">
  <collab>Live Dengue Vaccines Technical Consultation Reporting G</collab>, 
  <name>
   <surname>Bentsi-Enchill</surname>
   <given-names>AD</given-names>
  </name>, 
  <name>
   <surname>Schmitz</surname>
   <given-names>J</given-names>
  </name>, 
  <name>
   <surname>Edelman</surname>
   <given-names>R</given-names>
  </name>, 
  <name>
   <surname>Durbin</surname>
   <given-names>A</given-names>
  </name>, 
  <name>
   <surname>Roehrig</surname>
   <given-names>JT</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Long-term safety assessment of live attenuated tetravalent dengue vaccines: deliberations from a WHO technical consultation</article-title>. 
  <source>Vaccine</source>. 
  <year>2013</year>;
  <volume>31</volume>(
  <issue>23</issue>):
  <fpage>2603</fpage>â€“
  <lpage>9</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2013.03.038</pub-id>
  <?supplied-pmid 23570986?>
  <pub-id pub-id-type="pmid">23570986</pub-id>
 </mixed-citation>
</ref>
